# How Long Should we Give Steroids for Patients With Severe PCP

> **NCT07328984** · PHASE4 · NOT_YET_RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 416 (estimated)

## Conditions studied

- Pneumocystis Pneumonia
- Pneumocystis
- Pneumocystis Jirovecii Infection
- Pneumocystis Jiroveci Pneumonia
- Pneumocystis Carinii; Infection, Resulting From HIV Disease
- Pneumocystosis Associated With AIDS
- Pneumocystosis; Pneumonia (Etiology)

## Interventions

- **DRUG:** Systemic corticosteroids

## Key facts

- **NCT ID:** NCT07328984
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-30
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-06
- **Target enrollment:** 416 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07328984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07328984, "How Long Should we Give Steroids for Patients With Severe PCP". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07328984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*